ArticleJournal of materials chemistry2012
Location-tuned relaxivity in Gd-doped mesoporous silica nanoparticles.
Article in Journal of materials chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Slowing Down Water: Enhanced and Cation-responsive MRI Contrast.Angewandte Chemie (International ed. in English) · 2026Article
- AND-logic MRI contrast by water flux modulation.Chemical science · 2026Article
- Convergent Evolution: Self-Assembly of Small Molecule, Polymeric, and Inorganic Contrast Agents toward Advanced MRI.Journal of the American Chemical Society · 2025Review
- From Nanothermometry to Bioimaging: Lanthanide-Activated KYACS applied materials & interfaces · 2023Article
- Synthesis of triethoxysilylated cyclen derivatives, grafting on magnetic mesoporous silica nanoparticles and application to metal ion adsorption.RSC advances · 2021Article
- Mesoporous Silica Nanoparticles in Bioimaging.Materials (Basel, Switzerland) · 2020Review
- Magnetic Nanomaterials as Contrast Agents for MRI.Materials (Basel, Switzerland) · 2020Review
- Magnetic Nanoparticles Supporting Bio-responsiveMaterials (Basel, Switzerland) · 2019Review
- Functional Mesoporous Silica Nanocomposites: Biomedical applications and Biosafety.International journal of molecular sciences · 2019Review
- Nanoparticle-Based Paramagnetic Contrast Agents for Magnetic Resonance Imaging.Contrast media & molecular imaging · 2019Review
- Gd-Si Oxide Nanoparticles as Contrast Agents in Magnetic Resonance Imaging.Nanomaterials (Basel, Switzerland) · 2016Article
- Silica-coated Gd(DOTA)-loaded protein nanoparticles enable magnetic resonance imaging of macrophages.Journal of materials chemistry. B · 2015Article
- Silica nanoparticle-based dual imaging colloidal hybrids: cancer cell imaging and biodistribution.International journal of nanomedicine · 2015Article
- Engineering cytochrome-modified silica nanoparticles to induce programmed cell death.Chemistry (Weinheim an der Bergstrasse, Germany) · 2013Article
- Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.Nanotechnology · 2013Review
- Environmentally responsive MRI contrast agents.Chemical communications (Cambridge, England) · 2013Review
- MRI biosensors: a short primer.Journal of magnetic resonance imaging : JMRI · 2013Review
- Non-metallic nanomaterials in cancer theranostics: a review of silica- and carbon-based drug delivery systems.Science and technology of advanced materials · 2013Review
- High signal contrast gating with biomodified Gd doped mesoporous nanoparticles.Chemical communications (Cambridge, England) · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In tuning the sub-particle localisation of Gd(III) binding macrocycles within a mesoporous scaffold, nanoparticle contrast agents of unprecedented relaxivity and low Gd(III) loadings can be realised.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.